These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9395042)

  • 1. Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion.
    Anand S; Kudallur V; Pitman EB; Diamond SL
    Ann Biomed Eng; 1997; 25(6):964-74. PubMed ID: 9395042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
    Wu JH; Siddiqui K; Diamond SL
    Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of transport parameters and enzyme kinetics of the fibrinolytic system on thrombolysis: mathematical modelling of two idealised cases.
    Zidansek A; Blinc A
    Thromb Haemost; 1991 May; 65(5):553-9. PubMed ID: 1831302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction.
    Anand S; Diamond SL
    Circulation; 1996 Aug; 94(4):763-74. PubMed ID: 8772700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
    Wootton DM; Popel AS; Alevriadou BR
    Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering design of optimal strategies for blood clot dissolution.
    Diamond SL
    Annu Rev Biomed Eng; 1999; 1():427-62. PubMed ID: 11701496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numerical analysis of forced injection of enzyme during thrombolysis.
    Jeong WW; Rhee K
    Comput Biol Med; 2007 May; 37(5):655-62. PubMed ID: 16890215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport processes in fibrinolysis and fibrinolytic therapy.
    Blinc A; Francis CW
    Thromb Haemost; 1996 Oct; 76(4):481-91. PubMed ID: 8902982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner clot diffusion and permeation during fibrinolysis.
    Diamond SL; Anand S
    Biophys J; 1993 Dec; 65(6):2622-43. PubMed ID: 8312497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence of blood clot lysis on the mode of transport of urokinase into the clot--a magnetic resonance imaging study in vitro.
    Blinc A; Planinsic G; Keber D; Jarh O; Lahajnar G; Zidansĕk A; Demsar F
    Thromb Haemost; 1991 May; 65(5):549-52. PubMed ID: 1871717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occlusive thrombus formation on indwelling catheters: in vitro investigation and computational analysis.
    Friedrich P; Reininger AJ
    Thromb Haemost; 1995 Jan; 73(1):66-72. PubMed ID: 7740499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow.
    Piebalgs A; Xu XY
    J R Soc Interface; 2015 Dec; 12(113):20150949. PubMed ID: 26655469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical model for the dissolution of non-occlusive blood clots in fast tangential blood flow.
    Sersa I; Tratar G; Mikac U; Blinc A
    Biorheology; 2007; 44(1):1-16. PubMed ID: 17502685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis at the fluid-solid interface of thrombi.
    Kolev K; Longstaff C; Machovich R
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):341-55. PubMed ID: 16250865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the ADC and T2 mapping in an assessment of blood-clot lysability.
    Vidmar J; Blinc A; Sersa I
    NMR Biomed; 2010 Jan; 23(1):34-40. PubMed ID: 19642088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis modulates arterial drug distribution for drug-eluting stents.
    Hwang CW; Levin AD; Jonas M; Li PH; Edelman ER
    Circulation; 2005 Apr; 111(13):1619-26. PubMed ID: 15795325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis.
    Yamamoto J; Yamashita T; Ikarugi H; Taka T; Hashimoto M; Ishii H; Watanabe S; Kovacs IB
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):31-9. PubMed ID: 12544726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.